Skip to content

Treatment of acute oral poisoning with medicinal charcoal granules: a prospective multi-center real-world study

Treatment of acute oral poisoning with medicinal charcoal granules: a prospective multi-center real-world study

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091492
Enrollment
Unknown
Registered
2024-10-29
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute oral poisoning

Interventions

Out-patient Group:After the first dose of 50g, take 20g every 4-6 hours
In-patient Group 1:After the first dose of 100g, 20g was administered at 4-6 h intervals and continued for several days
In-patient Group 2:After the first dose of 50g, 20g was administered at 4-6 h intervals and continued for several days

Sponsors

Shandong Provincial Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: ? Patients with acute oral poisoning or overdose; ? age =14 years old; ? Informed consent was obtained from patients or their guardians. ? If the patient has disturbance of consciousness, the drug can be administered through an indwelling gastric tube with airway protection and the informed consent of the guardian.

Exclusion criteria

Exclusion criteria: ? Alcohol (e.g., ethanol, methanol, and diols, e.g., ethylene glycol), inorganic salts (e.g., sodium chloride), metals and their inorganic compounds (e.g., lithium, iron, or other heavy metals, e.g., lead or mercury), organic solvents (e.g., acetone, dimethyl sulfoxide, gasoline), acids and bases, cyanide poisoning; ? Exposure to toxins that inhibit gastrointestinal peristalsis (such as anticholinergic drugs, opioids, etc.); ? Disturbance of consciousness, no swallowing reflex, no airway protection; ? Gastrointestinal corrosion or bleeding, gastrointestinal damage or suspected perforation; ? Recurrent vomiting; ? Informed consent could not be obtained.

Design outcomes

Primary

MeasureTime frame
Mortality rate;

Secondary

MeasureTime frame
Blood/Urine toxin concentration;Blood routine examination;Liver and kidney function test, and biochemistry;Coagulation function;Myocardial marker;

Countries

China

Contacts

Public ContactZhang Xingguo

Shandong Provincial Hospital Affiliated to Shandong First Medical University

13964016466@163.com+86 151 6888 6207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026